NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lava Therapeutics B.V (NASDAQ: LVTX)

 
LVTX Technical Analysis
4
As on 23rd Nov 2022 LVTX SHARE Price closed @ 5.78 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.36 & Strong Sell for SHORT-TERM with Stoploss of 8.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LVTXSHARE Price

Open 5.78 Change Price %
High 5.85 1 Day 0.08 1.40
Low 5.66 1 Week 0.53 10.10
Close 5.78 1 Month 1.91 49.35
Volume 15800 1 Year -5.65 -49.43
52 Week High 11.43 | 52 Week Low 2.28
 
NASDAQ USA Most Active Stocks
COMS 0.08 14.29%
TSLA 183.20 7.82%
AMD 76.40 1.53%
AMZN 94.13 1.00%
AAPL 151.07 0.59%
SOFI 4.66 0.43%
NRBO 1.63 35.83%
NVDA 165.19 3.00%
FFIE 0.32 -3.03%
FB 169.49 -0.39%
 
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
QLGN 1.80 958.82%
SPCB 1.83 731.82%
CTXRW 0.14 600.00%
PMGMW 0.06 500.00%
GBRGW 0.10 233.33%
PONOW 0.10 233.33%
NDRAW 0.03 200.00%
BRLIW 0.03 200.00%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
BVXV 0.93 -89.91%
PTRAW 0.23 -89.59%
ACBAW 0.01 -88.89%
AMAOW 0.02 -71.43%
LDHAW 0.05 -66.67%
FTPAW 0.02 -66.67%
SKYAW 0.02 -60.00%
FMIVW 0.02 -60.00%
MILEW 0.06 -53.85%
ROCGW 0.01 -50.00%
 
 
LVTX
Daily Charts
LVTX
Intraday Charts
Whats New @
Bazaartrend
LVTX
Free Analysis
 
LVTX Important Levels Intraday
RESISTANCE6.15
RESISTANCE6.03
RESISTANCE5.96
RESISTANCE5.88
SUPPORT5.68
SUPPORT5.60
SUPPORT5.53
SUPPORT5.41
 
LVTX Forecast November 2022
4th UP Forecast16.63
3rd UP Forecast13.15
2nd UP Forecast11
1st UP Forecast8.85
1st DOWN Forecast2.71
2nd DOWN Forecast0.56
3rd DOWN Forecast-1.59
4th DOWN Forecast-5.07
 
LVTX Weekly Forecast
4th UP Forecast6.59
3rd UP Forecast6.33
2nd UP Forecast6.17
1st UP Forecast6.01
1st DOWN Forecast5.55
2nd DOWN Forecast5.39
3rd DOWN Forecast5.23
4th DOWN Forecast4.97
 
LVTX Forecast2022
4th UP Forecast23.3
3rd UP Forecast17.68
2nd UP Forecast14.21
1st UP Forecast10.73
1st DOWN Forecast0.83
2nd DOWN Forecast-2.65
3rd DOWN Forecast-6.12
4th DOWN Forecast-11.74
 
 
LVTX Other Details
Segment EQ
Market Capital 191898608.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
LVTX Address
LVTX
 
LVTX Latest News
 
Your Comments and Response on Lava Therapeutics B.V
 
LVTX Business Profile
Lava Therapeutics B.V., a biotechnology company, engages in developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its platform. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of CD1d-expressing hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. The company also develops its gamma-delta bsTCEs in solid tumors, which targets prostate-specific membrane antigen for the treatment of prostate cancer. Lava Therapeutics B.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of potential product candidates. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands. Address: Yalelaan 60, Utrecht, Netherlands, 3584 CM
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service